2020
DOI: 10.3390/chemosensors8040117
|View full text |Cite
|
Sign up to set email alerts
|

Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates

Abstract: Brain tumors, especially glioblastoma, remain the most aggressive form of all the cancers because of inefficient diagnosis and profiling. Nanostructures, such as metallic nanostructures, silica nano-vehicles, quantum dots, lipid nanoparticles (NPs) and polymeric NPs, with high specificity have made it possible to permeate the blood–brain barrier (BBB). NPs possess optical, magnetic and photodynamic properties that can be exploited by surface modification, bio composition, contrast agents’ encapsulation and coa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
47
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2
1

Relationship

6
4

Authors

Journals

citations
Cited by 117 publications
(47 citation statements)
references
References 208 publications
(168 reference statements)
0
47
0
Order By: Relevance
“…Currently, in pharmaceutical formulations, diverse mucilages have been employed as a binding factor and a drug excipient. Mucilage has good bonding activities compared to numerous synthetic materials [ 22 , 99 , 100 , 101 , 102 , 103 , 104 ]. In general, the use of mucilages in drug formulations includes their usage in the production of tablets [ 105 , 106 ], as an emulsifying and suspending agent [ 22 , 107 , 108 ], as a bioadhesive agent [ 109 ], as well as gelling and thickening agents [ 110 , 111 ].…”
Section: Plant-based Mucilages and Pharmaceutical Applicationsmentioning
confidence: 99%
“…Currently, in pharmaceutical formulations, diverse mucilages have been employed as a binding factor and a drug excipient. Mucilage has good bonding activities compared to numerous synthetic materials [ 22 , 99 , 100 , 101 , 102 , 103 , 104 ]. In general, the use of mucilages in drug formulations includes their usage in the production of tablets [ 105 , 106 ], as an emulsifying and suspending agent [ 22 , 107 , 108 ], as a bioadhesive agent [ 109 ], as well as gelling and thickening agents [ 110 , 111 ].…”
Section: Plant-based Mucilages and Pharmaceutical Applicationsmentioning
confidence: 99%
“…The enhanced surface area and high stability of nanosystems are responsible for improving the bioavailability and drug release profile. Moreover, the hydrophilic and hydrophobic drugs can be incorporated at the same time for the treatment and diagnosis [ 94 ]. Nanoparticulate drug systems mainly include polymeric NPs, dendrimers, micelles, liposomes, carbon-based nanovehicles, and metallic NPs.…”
Section: Nanomaterials For the Treatment Of Osamentioning
confidence: 99%
“…Nanomaterials can exert their innate antimicrobial action, and synthesizing NPs while conjugating them to antimicrobials may lead to synergistic antibacterial actions, with cost-effectiveness and higher stability for a longer period [ 37 ]. Antimicrobial NPs for UTIs are mostly based on metals (gold - Au, silver - Ag, titanium NPs) and on metal-based oxides (zinc oxide-ZnO-NPs) [ 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ]. All metal and metal-based oxide NP damage the pathogenic microorganisms by various mechanisms of photothermolysis, generating reacting oxygen species (ROS), damaging the cell wall and cell components of pathogens, and interfering with normal enzymatic activities and DNA synthesis [ 45 ].…”
Section: Introductionmentioning
confidence: 99%